JAK inhibitors reduce the SASP, frailty and fat dysfunction in old mice. ConfidenceEstablished Level of evidence●●●○○○ Laboratory mammals Observed inMouse MissionMap of aging (12 hallmarks) ConceptsCellular senescenceJAK inhibitors (ruxolitinib)Senescence-associated secretory phenotype (SASP)